Industry & Business

Edwards Lifesciences to Invest €80 Million in the Mid-West

 Breaking News
  • Finch Capital to Step Up Investment Activity in Irish Fintech Market Finch Capital, a leading early stage venture capital firm with offices in Amsterdam, London and Singapore, has announced that it now has an active presence in the Irish market and is dedicating up to €20 million to Irish start-ups in the fintech sector, following a €10 million investment from Enterprise Ireland. In 2018, Finch Capital closed [...]...
  • ESB and Coillte in Discussions to Deliver Renewable Energy Projects ESB is engaged in bilateral discussions with Coillte which, if successful, would lead to the establishment of a new joint venture development company to deliver 1,000 MW of renewable energy by 2030. It is proposed that a new joint venture will build on a successful track record of the two companies working together at Raheenleagh [...]...
  • Grocery Market Fends Off January Blues The Irish grocery market followed up a record-breaking festive period by posting year-on-year sales growth of 3.4% during the 12 weeks to 27 January. Despite shoppers tightening the purse strings, the latest figures from Kantar Worldpanel show a strong start to 2019 as New Year’s resolutions shaped shopping baskets. Douglas Faughnan, consumer insight director at Kantar [...]...
  • McAleer & Rushe Commences Construction on London Development Northern Ireland-based developer and contractor McAleer & Rushe has announced that construction is to commence on a new 620 room hotel and hybrid aparthotel development in Paddington, London with a contract value worth c.£82 million. Led by developer Concierge 3, a consortium of BSW Land & Property, Staycity and The Pickstock Group, the scheme is the final stage of the [...]...
  • Launch of 182,500 sq ft Seamark Building Marks Completion of Dublin 4 Redevelopment Project Chartered Land has announced that the major €45 million transformation of the eight storey 182,500 sq ft Seamark Building at the Elmpark Green campus in Dublin 4 is now complete. The completion of the Seamark Building, prominently located at the front of the campus with panoramic views over Dublin Bay, brings an end to the [...]...

Edwards Lifesciences to Invest €80 Million in the Mid-West

Edwards Lifesciences to Invest €80 Million in the Mid-West
March 09
10:07 2018

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has announced that the company, headquartered in Irvine, California, USA, has chosen the Mid-West of Ireland for the location of a new plant to manufacture delivery components for its transcatheter heart valve therapies. This new addition to Edwards’ global supply network, which includes a similar existing facility in the United States, will initially be configured to support the manufacturing of therapies that enable minimally invasive procedures on patients’ aortic, mitral and tricuspid valves, where open heart surgery would previously have been the norm.

“The arrival of Edwards Lifesciences is a vote of confidence in the Mid-West region as a destination for high-end medical technology manufacturers,” said Minister Heather Humphreys. “It will provide even more opportunities for local residents and communities to grow and thrive. My department, through the IDA, is committed to supporting Edwards as it establishes operations in Ireland and as the company continues to develop its innovative heart valve technologies.”

Edwards is planning to hire approximately 60 people this year in various functions, such as production staff, engineering and professional management, to work at its initial site located in the Shannon Free Zone.

The company plans to complete a new, purpose-built manufacturing facility in the Mid-West of Ireland in 2020. Once the facility is fully operational, the company expects it will employ approximately 600 people. Edwards’ investment in the project is expected to amount to approximately €80 million.

“The addition of a manufacturing location in Ireland is an element of Edwards’ global supply strategy to support future growth and reliability of supply, and continues the growth in employment Edwards has experienced both in the United States and around the world,” said Joe Nuzzolese, Edwards’ corporate vice president, global supply chain. “Choosing this location included many considerations, but an important one is a talented workforce with experience in medical technology.  We look forward to becoming an integral part of the local community through engagement and philanthropic support, and providing educational and professional opportunities for our employees.  We are excited to welcome these new associates into Edwards, with the shared goal of serving more patients around the world by delivering high quality life-saving technologies.”

The company expects to begin hiring new employees in Shannon by June. People interested in applying for a position can find out more information and submit applications at www.edwards.com/irelandjobs.

“This announcement by Edwards Lifesciences that it is establishing a new manufacturing facility in the Mid-West is terrific news for the region and for Ireland,” said Martin Shanahan, CEO of IDA Ireland.  “The company’s arrival further enhances Ireland’s reputation as a preferred location for leading companies in the lifesciences sector. Winning investment for regional locations is a key focus for IDA Ireland and this project is an excellent one to secure for this region.”

This project is supported by the government through IDA Ireland.

About Author

admin

admin

Related Articles

New Subscriber

Subscribe Here



Advertisements




















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4